4//SEC Filing
Paulson Richard A. 4
Accession 0001193125-25-241471
CIK 0001503802other
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 4:29 PM ET
Size
4.8 KB
Accession
0001193125-25-241471
Insider Transaction Report
Form 4
Paulson Richard A.
DirectorPresident and CEO
Transactions
- Award
Common Stock
2025-10-15+114,285→ 198,331 total
Footnotes (1)
- [F1]Represents the award of restricted stock units ("RSUs") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan, as amended. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest 100% on December 31, 2026.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001804460
Filing Metadata
- Form type
- 4
- Filed
- Oct 15, 8:00 PM ET
- Accepted
- Oct 16, 4:29 PM ET
- Size
- 4.8 KB